2SEVENTY BIO INC shareholders Q3 2023

2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q3 2023. The put-call ratio across all filers is 3.19 and the average weighting 0.1%.

2SEVENTY BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Kynam Capital Management, LP 5,953,825$23,338,9943.82%
Newtyn Management, LLC 3,076,490$12,059,8412.98%
DAFNA Capital Management LLC 1,447,465$5,674,0631.76%
CHI Advisors LLC 1,002,007$3,927,8671.56%
AlphaCentric Advisors LLC 657,500$2,577,4001.46%
Casdin Capital, LLC 2,023,913$7,933,7390.88%
Madison Avenue Partners, LP 1,494,125$5,856,9700.83%
Bain Capital Life Sciences Investors, LLC 1,408,901$5,522,8920.62%
Eversept Partners, LP 1,453,378$5,697,2420.48%
Engine Capital Management, LP 341,870$1,340,1300.30%
CLOUGH CAPITAL PARTNERS L P 510,910$2,002,7670.22%
Birchview Capital, LP 59,833$234,5450.20%
Boxer Capital, LLC 459,836$1,802,5570.10%
BROWN WEALTH MANAGEMENT, LLC 50,000$196,0000.09%
SHERBROOKE PARK ADVISERS LLC 57,432$225,1330.07%
Quantamental Technologies LLC 19,109$74,9070.07%
Virtus ETF Advisers LLC 28,308$110,9670.07%
Baker Brothers Advisors 2,497,526$9,790,3020.06%
ExodusPoint Capital Management, LP 1,389,953$5,4490.05%
ELCO Management Co., LLC 17,051$66,8400.05%

This page lists 2SEVENTY BIO INC's shareholders in Q3 2023. To view 2SEVENTY BIO INC's shareholder history, click here.